Graft-Versus-Host Disease

Graft-Versus-Host Disease

  • add an accredited certificate for this course here
Purchase Continuing Education Credit: 

Accreditation

Accredited Course

Cost: $40

Courses that have the CE logo on the image have a designated number of certified continuing education credits associated with the course. These courses have a fee, and upon completion, the learner will receive a certificate with their designated credits which can be used for re-licensure. The continuing education credits available for this course are physician credits, MOC Part II credits, nursing credits and pharmacy credits.


Accreditation/Designation Statements

In support of improving patient care, Boston Children's Hospital is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for the healthcare team.

Physician

Boston Children's Hospital designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in this activity.

MOC Part II

American Board of Pediatrics

Successful completion of this CME activity, which includes participation in the activity, with individual assessment of the participant and feedback to the participant, enables the participant to earn 1.00 MOC points in the American Board of Pediatrics' (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

American Board of Internal Medicine

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nurse

Boston Children's Hospital designates this activity for 1.00 contact hours for nurses. Nurses should only claim credit commensurate with the extent of their participation in the activity.

Pharmacy

This activity (JA0008063-0000-18-076-H01-P) carries a maximum of 1.00 contact hours

Course Information

About

This course reviews Acute and Chronic Graft versus Host Disease (GVHD) including its pathophysiology, risk factors, diagnostic features, grading, prevention and treatment, as well as prognosis. The course is intended for physicians, nurses and pharmacists who provide care for infants and children that may require a hematopoietic stem cell transplant which puts them at risk for GVHD. It addresses the need for improved healthcare provider education on the heterogeneous clinical presentations and management of acute and chronic GVHD. Informed healthcare providers will be able to better assess and provide effective treatment to pediatric patients who develop GVHD following stem cell transplant.

Instructional Time

1 hour, 07 minutes

Cost

  • Accredited Course: $40

Target Audience

  • Physicians
  • Nurses
  • Pharmacists

Expiration Dates

  • Approved: 07/09/2019
  • Released: 07/17/2019
  • Expires: 07/09/2022

Course Format

Self-paced, using text and video, with a post-test assessment. Requires 80% or higher score to earn CME credit. Online course assessment. Requires Safari (v6 or higher), Chrome (v38 or higher), Internet Explorer (v11 or higher), or Firefox (v23 or higher).

Privacy Policy

Access the Boston Children's Hospital CME Privacy Policy here.

Learning Objectives

  • Define acute and chronic GVHD
  • Describe the pathophysiology of acute and chronic GVHD
  • Identify risk factors for GVHD in pediatric stem cell transplant patients
  • Compare and contrast dagnostic and distinctive features of acute vs. chronic GVHD
  • List how acute GVHD is graded and staged in pediatric stem cell transplant patients
  • Identify prophylactic and treatment regimens for GVHD

Contributors

Course Director(s)

Traci Wolbrink, MD
Senior Associate, Critical Care Medicine
Boston Children's Hospital

Author(s)

Christine Duncan, MD
Attending Physician
Boston Children's Hospital

Disclosures

In accordance with the disclosure policy of Boston Children's Hospital and the standards set forth by the Accreditation Council for Continuing Medical Education, course planners, speakers and content reviewers list below any relevant relationships they or their spouse/partner have to companies producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients.

Course Director(s)

No disclosures to report:

Traci Wolbrink, MD, MPH

Author(s)

The following individual(s), on behalf of themselves and their spouse or partner, have reported relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on patients:

Christine Duncan, MD

Course Reviewer(s)

No disclosures to report:

Kathleen Huth, MD, MMSc; Michele DeGrazia, PhD, RN, NNP, FAAN; Sara Drumm, RN, CCRN; Emily Hamilton, MSN, CCRN, NP-C; Brienne Leary, RN, BSN, CPON, CCRN; Liza Li, PharmD; Shannon Manzi, PharmD

Commercial and Financial Support Disclosure

This program receives no commercial support.